Detalhe da pesquisa
1.
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
N Engl J Med
; 386(3): 241-251, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534430
2.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Lancet Oncol
; 25(4): 439-454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547891
3.
Locally Advanced, Unresectable Non-Small Cell Lung Cancer.
Curr Oncol Rep
; 22(4): 31, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140986
4.
Race-inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
Cancer
; 129(23): 3692-3693, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728029
5.
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical Care.
J Mol Diagn
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777037
6.
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299.
JTO Clin Res Rep
; 4(12): 100584, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38046376
7.
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.
Cancers (Basel)
; 15(9)2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173987
8.
Combination IFNß and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
Cancer Immunol Res
; 11(4): 466-485, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757308
9.
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation.
J Thorac Dis
; 15(11): 6115-6125, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090314
10.
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Lung Cancer
; 183: 107313, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499521
11.
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 837-848, 2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657497
12.
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.
Radiother Oncol
; 167: 116-121, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953934
13.
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
PLoS One
; 16(7): e0252041, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197475
14.
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 109(2): 425-435, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002543
15.
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Nat Med
; 27(8): 1410-1418, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385708
16.
Breaking the Impasse: Advances in Treatment of Small Cell Lung Cancer.
Clin Chest Med
; 41(2): 269-280, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402362
17.
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
Front Oncol
; 10: 1074, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766139
18.
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.
Clin Cancer Res
; 25(22): 6623-6632, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409616
19.
Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer.
J Thorac Dis
; 10(Suppl 3): S433-S450, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593889
20.
Clinical associations of mucin 1 in human lung cancer and precancerous lesions.
Oncotarget
; 9(86): 35666-35675, 2018 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479696